Abattis Bioceuticals ATTBF Stock
Abattis Bioceuticals Price Chart
Abattis Bioceuticals ATTBF Financial and Trading Overview
| Abattis Bioceuticals stock price | 0.0001 USD |
| Previous Close | 1.0E-6 USD |
| Open | 1.0E-5 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 1.0E-5 - 1.0E-5 USD |
| 52 Week Range | 1.0E-5 - 0.0001 USD |
| Volume | 2K USD |
| Avg. Volume | 1.88K USD |
| Market Cap | 4.73M USD |
| Beta (5Y Monthly) | -61.72183 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.08 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
ATTBF Valuation Measures
| Enterprise Value | -2660757 USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 13.254632 |
| Price/Book (mrq) | 0.0004347826 |
| Enterprise Value/Revenue | -7.456 |
| Enterprise Value/EBITDA | 0.693 |
Trading Information
Abattis Bioceuticals Stock Price History
| Beta (5Y Monthly) | -61.72183 |
| 52-Week Change | 0% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.0001 USD |
| 52 Week Low | 1.0E-5 USD |
| 50-Day Moving Average | 1.0E-5 USD |
| 200-Day Moving Average | 2.41E-5 USD |
ATTBF Share Statistics
| Avg. Volume (3 month) | 1.88K USD |
| Avg. Daily Volume (10-Days) | 200 USD |
| Shares Outstanding | 477.8M |
| Float | 475.9M |
| Short Ratio | N/A |
| % Held by Insiders | 0% |
| % Held by Institutions | 0.017% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:5 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | September 30, 2019 |
| Most Recent Quarter (mrq) | September 30, 2019 |
| Next Fiscal Year End | September 30, 2020 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -1095.65% |
| Gross Margin | 67.62% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -15.94% |
| Return on Equity (ttm) | -28.12% |
Income Statement
| Revenue (ttm) | 356.88K USD |
| Revenue Per Share (ttm) | 0.001 USD |
| Quarterly Revenue Growth (yoy) | 9064.29% |
| Gross Profit (ttm) | 241.34K USD |
| EBITDA | -3837725 USD |
| Net Income Avi to Common (ttm) | -3042005 USD |
| Diluted EPS (ttm) | -0.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 2.4M USD |
| Total Cash Per Share (mrq) | 0.005 USD |
| Total Debt (mrq) | 150.86K USD |
| Total Debt/Equity (mrq) | 1.41 USD |
| Current Ratio (mrq) | 0.733 |
| Book Value Per Share (mrq) | 0.023 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 9.41M USD |
| Levered Free Cash Flow (ttm) | -2456610 USD |
Profile of Abattis Bioceuticals
| Country | United States |
| State | BC |
| City | Vancouver |
| Address | 625 Howe Street |
| ZIP | V6C 2M6 |
| Phone | 808 650 3007 |
| Website | https://www.abattis.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada. The company develops and licenses natural health products, medicines, extractions, and ingredients for the biological, nutraceutical, bioceutical, and cosmetic markets. It also provides Comfort, a cannabinoid enhanced nutraceutical for pain and inflammation; and Health-Canada licensed services for the cannabis industry. The company was formerly known as Abattis Biologix Corporation and changed its name to Abattis Bioceuticals Corporation in September 2012. Abattis Bioceuticals Corp. was incorporated in 1997 and is headquartered in Vancouver, Canada.
Q&A For Abattis Bioceuticals Stock
What is a current ATTBF stock price?
Abattis Bioceuticals ATTBF stock price today per share is 0.0001 USD.
How to purchase Abattis Bioceuticals stock?
You can buy ATTBF shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Abattis Bioceuticals?
The stock symbol or ticker of Abattis Bioceuticals is ATTBF.
Which industry does the Abattis Bioceuticals company belong to?
The Abattis Bioceuticals industry is Drug Manufacturers-Specialty & Generic.
How many shares does Abattis Bioceuticals have in circulation?
The max supply of Abattis Bioceuticals shares is 47.3B.
What is Abattis Bioceuticals Price to Earnings Ratio (PE Ratio)?
Abattis Bioceuticals PE Ratio is now.
What was Abattis Bioceuticals earnings per share over the trailing 12 months (TTM)?
Abattis Bioceuticals EPS is -0.08 USD over the trailing 12 months.
Which sector does the Abattis Bioceuticals company belong to?
The Abattis Bioceuticals sector is Healthcare.